In addition to the transcriptional downregulation of MYC [22], CBL0137 is known to exert anti-cancer activity by inhibiting the NF-kβ pathway and via trapping of SSRP1 into chromatin [15, 17, 18]. This evidence concerns the gene NFKB1 and cancer.